The Gluten-Free Brief – June 7, 2026

The Gluten-Free Brief: Policy, science, global developments.

Celiac disease raises the risk of death, heart disease, and organ failure — and two new studies published this week put the numbers on paper for the first time in the U.S. This edition also covers a landmark labeling bill, a stalled compensation law in Spain, and how major league baseball is stepping up for the celiac community.

Celiac disease is associated with an 18% higher risk of death.

Tracking 204,000 adults across 71 U.S. healthcare systems, researchers also found an 11% higher risk of major cardiovascular events and a 51% higher risk of non-Hodgkin lymphoma. The study did not assess gluten-free diet adherence.
Source: Ludvigsson et al., The Lancet Regional Health – Americas, May 28, 2026

Barley and rye may finally get proper allergen labeling in the U.S.

Representatives Cleaver and McCollum introduced the Celiac Safety Act on May 28 — the first federal proposal to require the FDA to list barley and rye alongside wheat as major food allergens.
Source: Celiac Disease Foundation / Fox4 Kansas City, May 28, 2026

Spain’s celiac compensation law has been extended 22 times.

Seven months after lawmakers overwhelmingly approved a bill proposing a national celiac registry and a €600 annual tax deduction per diagnosed family member, patient groups across Spain are still waiting.
Source: FACE / Europa Press, June 2, 2026

Celiac awareness is hitting major league baseball across the U.S. this season.

CDF partnered with the Red Sox and Rays on Celiac Awareness Nights featuring gluten-free dining initiatives and cross-contact protocols, while Beyond Celiac ran a parallel “Strike Out Celiac” campaign with the Yankees and Cubs.
Source: MLB.com / CDF / Beyond Celiac, May 2026

Celiac disease is associated with nearly triple the risk of needing a solid organ transplant.

A Columbia University study tracking 41,277 people over 12 years found the highest increase was seen for liver transplants, supporting earlier celiac screening in some patients with chronic liver or kidney disease.
Source: Doyle et al., Clinical Gastroenterology and Hepatology, May 28, 2026


Informational news roundup; no endorsement implied. This blog post is for educational purposes only and does not replace medical advice from your own healthcare team.

Previous editions of The Gluten-Free Brief can be found here and on our social media channels.

Share the Post:

Related Posts

The Gluten-Free Brief: Policy, science, global developments.

The Gluten-Free Brief – May 22, 2026

Celiac disease raises the risk of eating disorders, a new drug shows effects beyond the gut, and a popular podcast reminded us why awareness still matters. This edition covers the latest research, recalls, and what the celiac community is talking about right now.

Read More
The Gluten-Free Brief: Policy, science, global developments.

The Gluten-Free Brief – May 7, 2026

The latest edition of The Gluten-Free Brief covers major new celiac research, undiagnosed case estimates from Ireland, Québec, and the UK, gluten-related recalls in Canada, a U.S. court ruling on gluten-free meals, and formulation changes affecting Peanut M&M’s in New Zealand.

Read More